These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34616711)

  • 1. Permeability Data of Organosulfur Garlic Compounds Estimated by Immobilized Artificial Membrane Chromatography: Correlation Across Several Biological Barriers.
    Ramirez DA; Federici MF; Altamirano JC; Camargo AB; Luco JM
    Front Chem; 2021; 9():690707. PubMed ID: 34616711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs.
    Grumetto L; Russo G; Barbato F
    Mol Pharm; 2016 Aug; 13(8):2808-16. PubMed ID: 27377191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immobilized artificial membrane chromatography: quantitative structure-retention relationships of structurally diverse drugs.
    Luco JM; Salinas AP; Torriero AA; Vázquez RN; Raba J; Marchevsky E
    J Chem Inf Comput Sci; 2003; 43(6):2129-36. PubMed ID: 14632465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.
    Grumetto L; Carpentiero C; Di Vaio P; Frecentese F; Barbato F
    J Pharm Biomed Anal; 2013 Mar; 75():165-72. PubMed ID: 23261809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
    Grumetto L; Russo G; Barbato F
    Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and mechanism elucidation of analyte retention on phospholipid stationary phases (IAM-HPLC) by in silico calculated physico-chemical descriptors.
    Russo G; Grumetto L; Barbato F; Vistoli G; Pedretti A
    Eur J Pharm Sci; 2017 Mar; 99():173-184. PubMed ID: 27919703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data.
    Grumetto L; Carpentiero C; Barbato F
    Eur J Pharm Sci; 2012 Apr; 45(5):685-92. PubMed ID: 22306648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols.
    Stępnik KE; Malinowska I
    J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polar interactions drug/phospholipids estimated by IAM-HPLC vs cultured cell line passage data: Their relationships and comparison of their effectiveness in predicting drug human intestinal absorption.
    Grumetto L; Russo G; Barbato F
    Int J Pharm; 2016 Mar; 500(1-2):275-90. PubMed ID: 26780120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Blood-Brain Barrier Permeability of Potential Heterocyclic Drugs via Biomimetic IAM Chromatography Technique Combined with QSAR Methodology.
    Janicka M; Sztanke M; Sztanke K
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors.
    Chan EC; Tan WL; Ho PC; Fang LJ
    J Chromatogr A; 2005 Apr; 1072(2):159-68. PubMed ID: 15887485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity of Antifungal Isoxazolo[3,4-
    Ciura K; Fedorowicz J; Žuvela P; Lovrić M; Kapica H; Baranowski P; Sawicki W; Wong MW; Sączewski J
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention behavior of flavonoids on immobilized artificial membrane chromatography and correlation with cell-based permeability.
    Tsopelas F; Tsagkrasouli M; Poursanidis P; Pitsaki M; Vasios G; Danias P; Panderi I; Tsantili-Kakoulidou A; Giaginis C
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29044623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of immobilized artificial membrane chromatography to predict human oral absorption.
    Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A
    Eur J Pharm Sci; 2016 Jan; 81():82-93. PubMed ID: 26485055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures.
    Valko K; Du CM; Bevan CD; Reynolds DP; Abraham MH
    J Pharm Sci; 2000 Aug; 89(8):1085-96. PubMed ID: 10906732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
    Kotecha J; Shah S; Rathod I; Subbaiah G
    Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between human intestinal absorption and polar interactions drug/phospholipids estimated by IAM-HPLC.
    Grumetto L; Russo G; Barbato F
    Int J Pharm; 2015 Jul; 489(1-2):186-94. PubMed ID: 25917756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Pharmacokinetic Properties of Potential Anticancer Agents via Their Chromatographic Behavior on Different Reversed Phase Materials.
    Janicka M; Mycka A; Sztanke M; Sztanke K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can protonated beta-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC).
    Barbato F; di Martino G; Grumetto L; La Rotonda MI
    Eur J Pharm Sci; 2005; 25(4-5):379-86. PubMed ID: 15979535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.